期刊文献+

氮芳基取代靛红的合成研究

Synthesis of N-aryl substituted isatin
下载PDF
导出
摘要 以靛红、芳基硼酸化合物为原料,经过Ullmann反应,合成了6个含有大体系的氮芳基取代的靛红衍生物.合成化合物的结构运用核磁共振氢谱、碳谱、红外光谱、高分辨质谱的技术手段进行了表征,为进一步研究靛红衍生物的光学性质及生物活性奠定了一定的物质基础.进一步研究发现,在Ullmann反应条件下,靛红能发生自身缩合反应.芳基硼酸能被铜试剂氧化生成1,2-二羰基化合物. Six nitrogen-substituted isatin derivatives bearing a large-conjugated system were synthesized through Ullmann reaction with isatin and arylboronic acid compounds as substrates.These compounds were characterized by 1H NMR,13C NMR,IR and HRMS.It provides a solid base for further investigation of optimal properties and biological activities of these isatin compounds.Further investigation found that condensation reaction took place with isatin under Ullmann reaction conditions.And arylboronic acid 5c was oxidized by Cu(OAc)2 to afford the byproduct 8.
作者 卞子龙 孙文武 吴滨 BIAN Zilong;SUN Wenwu;WU Bin(School of Pharmaceutical Sciences,South-Central University for Nationalities,Wuhan 430074,China)
出处 《中南民族大学学报(自然科学版)》 CAS 2020年第2期123-127,共5页 Journal of South-Central University for Nationalities:Natural Science Edition
基金 国家自然科学基金资助项目(21772236)。
关键词 靛红 ULLMANN反应 大体系 isatin Ullmann reaction large-conjugated system
  • 相关文献

参考文献1

二级参考文献6

  • 1FDA.http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm? fuseaction = Search..Overview&DrugName =SUTENT[EB/OL],2006-01-26.
  • 2ABRAM T J,LEE L B,MURRAY L J,et al.SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer[J].Molecular Cancer Ther,2003,2:471-478.
  • 3MENDEL D B,LAIRD A D,XIN X,et al.In vivo antitumor activity of Su11248,a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors:Determination of a pharmacokinetic / pharmacodynamic relationship[J].Clin Cancer Res,2003,9:327-337.
  • 4CASALI P G, GARRETF C R, BLACKSTEIN M E, et al. Updated results from a phase Ⅲ trial of Sunitinib in GIST patients for whom imatinib therapy has failed due to resistance or intolerance[J]. J Clini Oncol,2006,24(18) :9513.
  • 5MOTZER R J,MICHAELSON M D,REDMAN B G,et al.Activity of SU11248,a multiargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor,in patients with metastatic renal cell carcinoma[J].J Clini Oncol,2006,24(1):16-24.
  • 6MOTZER R J,RINI B I,BUKOWSKI R M,et al.Sunitinib in patients with metastatic renal cell carcinoma[J].JAMA,2006,295 (21):2516-2524.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部